Esperovax

Plymouth, US · 2 known investors

Esperovax is a biotechnology company developing an oral mRNA-based vaccine and biotherapeutic platform that produces shelf-stable vaccines in tablet and capsule form as an alternative to injection-based treatments. Its technology uses genetically modified probiotics and yeast-based virus-like particle secretion to deliver therapeutics for treatable diseases.

BiotechDeep Tech